GlaxoSmithKline Pharmaceuticals net sales up 12% in third quarter of FY 2009

Written by Businesswire India | Mumbai | Updated: Oct 30 2009, 19:54pm hrs
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the third quarter ended 30th September 2009.

The Company posted Net Sales growth of 12% compared to the previous quarter, while Profit before Investment Income and Taxes grew by 13% on a comparable basis.

Commenting on the performance, Dr. Hasit B. Joshipura, Managing Director, said, Sales during the quarter have shown growth across mass, mass speciality, vaccines and speciality therapies. Recent launches of Tykerb for refractory breast cancer, Benitec an anti-hypertensive drug from Daiichi Sankyo and Cervarix for cervical cancer are making steady progress. Vaccines have recorded strong growth with the rotaviral diarrhea vaccine tracking ahead of plan".